View Document Preview and Link Document Date: 2014-03-05 12:00:05 Open Document File Size: 369,03 KB Share Result on Facebook
Company NEW LIMITED / QuickLinks New Limited / NEW BENEFITS Limited / JAMP ASA / DIN BRAND NAME LCA STATUS PRICE 2325713 CO / MYLAN / DIN DRUG NAME 2315424 CO / / Currency pence / USD / / Facility College of Pharmacists / / IndustryTerm claims processing / mL solution / treatment of psoriasis / combination product / generic quetiapine products / cold chain / besylate products / / MedicalCondition Plaque Psoriasis / H1N1 flu / severe plaque psoriasis / osteoporosis / psoriasis / / MedicalTreatment vaccinations / vaccination / / MusicGroup B.C. / / Organization College of Pharmacists of BC / Pharmaceutical Services Division / Local Health Unit / B.C. government / Special Authority / RDP Special Authority / / Position Governor / certified pharmacist / / Product Humira / LEVOFLOXACIN / 100mg / FOSAMAX / OLANZAPINE / DIOVAN / CEFEPIME FOR INJECTION / IU tablet / VALSARTAN / EXJADE / Enbrel / BICALUTAMIDE / ALENDRONATE SODIUM / OMNARIS / Amlodipine Besylate / 25mg / Remicade / VIREAD / ACCORD / ZYPREXA ZYDIS / Oral Disintegrating Tablet / HYDROCHLOROTHIAZIDE / ZYPREXA / NAME LCA STATUS OLANZAPINE 5mg ODT 2327562 2303191 / / ProvinceOrState British Columbia / / URL www.health.gov.bc.ca/pharmacare/sa/criteria/formsindex.html / www.health.gov.bc.ca/pharmacare/suppliers.html / www.gov.bc.ca/h1n1/healthcareproviders / www.health.gov.bc.ca/pharmacare / www.health.gov.bc.ca/pharmacare/sa/criteria/restricted/alendronate.html / www.health.gov.bc.ca/pharmacare/sa/saindex.html / / SocialTag 
BCPharmaCare Newsletter November 18, 2009 Edition[removed]Published by the Pharmaceutical Services Division to provide information for British Columbia’s health care providers